control group:concurrent radiochemotherapy

2 trials

Sponsors

The First Medical Center of the PLA General Hospital, Sun Yat-Sen University Cancer Center

Conditions

Head and neck cancer exclude nasopharyngeal carcinomaRectal cancer

Phase 2

Endostatin in Concurrent Chemoradiotherapy of head and neck cancer: A Randomized Controlled Prospective Study

Active, not recruitingChiCTR-TRC-08000280

Sun Yat-Sen University Cancer CenterHead and neck cancer exclude nasopharyngeal carcinoma

Start: 2009-01-01Updated: 2017-04-18

Clinical study of Pabolizumab combined with radiotherapy for neoadjuvant therapy of advanced low and middle rectal cancer

RecruitingChiCTR2100045988

The First Medical Center of the PLA General HospitalRectal cancer

Start: 2021-05-01Updated: 2021-12-13